This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2001 May;120(6):1567-8.

doi: 10.1053/gast.2001.24495.

Intractable insomnia after cessation of treatment with thalidomide

M R Fox, A Harris

PMID: 11339241
DOI: 10.1053/gast.2001.24495

Case Reports

Intractable insomnia after cessation of treatment with thalidomide

M R Fox et al. Gastroenterology. 2001 May.

. 2001 May;120(6):1567-8.

doi: 10.1053/gast.2001.24495.

Authors

M R Fox, A Harris

PMID: 11339241
DOI: 10.1053/gast.2001.24495

Erratum in

Gastroenterology 2001 Sep;121(3):747

No abstract available

PubMed Disclaimer

Comment on

Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial.
Ehrenpreis ED, Kane SV, Cohen LB, Cohen RD, Hanauer SB. Ehrenpreis ED, et al. Gastroenterology. 1999 Dec;117(6):1271-7. doi: 10.1016/s0016-5085(99)70276-3. Gastroenterology. 1999. PMID: 10579967 Clinical Trial.
An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease.
Vasiliauskas EA, Kam LY, Abreu-Martin MT, Hassard PV, Papadakis KA, Yang H, Zeldis JB, Targan SR. Vasiliauskas EA, et al. Gastroenterology. 1999 Dec;117(6):1278-87. doi: 10.1016/s0016-5085(99)70277-5. Gastroenterology. 1999. PMID: 10579968 Clinical Trial.
Thalidomide for Crohn's disease.
Fishman SJ, Feins NR, D'Amoto RJ, Folkman J. Fishman SJ, et al. Gastroenterology. 2000 Aug;119(2):596. doi: 10.1053/gast.2000.16152. Gastroenterology. 2000. PMID: 10960273 No abstract available.

Similar articles

Thalidomide in Crohn disease and the risk of peripheral neuropathy.
Ahmed M, El-Hadi S, Jenkins HR. Ahmed M, et al. J Pediatr Gastroenterol Nutr. 2003 Oct;37(4):522. doi: 10.1097/00005176-200310000-00023. J Pediatr Gastroenterol Nutr. 2003. PMID: 14508228 No abstract available.
Thalidomide in Crohn disease.
Pigott A, Casson D. Pigott A, et al. J Pediatr Gastroenterol Nutr. 2005 Feb;40(2):236. doi: 10.1097/00005176-200502000-00035. J Pediatr Gastroenterol Nutr. 2005. PMID: 15699709 No abstract available.
Thalidomide-induced sensory neuropathy.
Strauss RS, Das KM. Strauss RS, et al. J Pediatr Gastroenterol Nutr. 2001 Mar;32(3):322-4. doi: 10.1097/00005176-200103000-00017. J Pediatr Gastroenterol Nutr. 2001. PMID: 11345184 No abstract available.
Mucosal healing with thalidomide in refractory Crohn's disease patients intolerant of anti-TNF-α drugs: report of 3 cases and literature review.
Scribano ML, Cantoro L, Marrollo M, Cosintino R, Kohn A. Scribano ML, et al. J Clin Gastroenterol. 2014 Jul;48(6):530-3. doi: 10.1097/MCG.0000000000000122. J Clin Gastroenterol. 2014. PMID: 24667589 Review.
Thalidomide in gastrointestinal disorders.
Bousvaros A, Mueller B. Bousvaros A, et al. Drugs. 2001;61(6):777-87. doi: 10.2165/00003495-200161060-00006. Drugs. 2001. PMID: 11398909 Review.

See all similar articles

Cited by

Tumor necrosis factor alpha in sleep regulation.
Rockstrom MD, Chen L, Taishi P, Nguyen JT, Gibbons CM, Veasey SC, Krueger JM. Rockstrom MD, et al. Sleep Med Rev. 2018 Aug;40:69-78. doi: 10.1016/j.smrv.2017.10.005. Epub 2017 Nov 17. Sleep Med Rev. 2018. PMID: 29153862 Free PMC article. Review.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information